Stocks of Exact Sciences - Current price, Where to buy? Chart
| Detail | Data |
|---|---|
| Stocks: | Exact Sciences |
| ompany Name: | Exact Sciences Corporation |
| Ticker: | EXAS |
| Exchange: | NasdaqCM |
| Outstanding stocks: | 183,850,000 |
| 24-hour Volume: | 1,569,334 |
| Industry: | Diagnostics & Research |
| Sector: | Healthcare |
| Number of Employees: | 6500 |
| Country: | United States |
| City: | Madison |
| Address: | 5505 Endeavor Lane |
| P/E Ratio: | Forward P/E | EPS: | Forward EPS | Book value per share | Market capitalization |
|---|---|---|---|---|---|
| / | 1009.00 | -1.13 USD | 0.06 USD | 17.34 USD | 11,130,278,912.00 USD |
| P/E Ratio: | / |
|---|---|
| Forward P/E: | 1009.00 |
| EPS: | -1.13 USD |
| Forward EPS: | 0.06 |
| Book value per share: | 17.34 USD |
| Market capitalization: | 11,130,278,912.00 USD |
Exact Sciences
Fundamental Indicators
| Indicator | Data |
|---|---|
| Total Revenue: | 2,499,766,016.00 USD |
| Net Income: | -204,148,992.00 USD |
| Price-to-Book (P/B) Ratio: | 3.49 |
| PEG Ratio: | -0.72 |
Note: The data is approximate, subject to change over time, and may not be current; however, we strive for the highest possible accuracy.
Analysts' predictions
| Analysts | Recommendation |
|---|---|
| Issued Recommendation: | According to our data, the recommendation issued for Exact Sciences stocks is: buy |
| Number of Analysts: | 20 |
| Highest Target Price: | 115 USD |
| Lowest Target Price: | 66 USD |
| Average Target Price: | 89.6 USD |
Note: The data is approximate. Recommendations and price forecasts for Exact Sciences stocks based on analysts' ratings may change over time. Some recommendations may already be outdated and may not be accurate. We strongly advise against buying and selling stocks based on analysts' recommendations!
Dividend
| Dividends | Value |
|---|---|
| Dividend Amount | According to our data, the company Exact Sciences is currently not paying dividends. |
| Annual Yield %: | - |
| Ex-dividend Date: | - |
| Average % Yield for 5 Years: | - |
| Payout Ratio: | - |
| Value of Last Dividend Paid: | - |
| Date of Last Dividend: | - |
The dividend is displayed for the entire calendar year, however, it is usually paid out quarterly in parts. Data may change!
Where to Buy Exact Sciences Stocks?
If you're interested in investing in Exact Sciences stocks and believe in their future growth, you can purchase them through stock brokers like XTB or eToro. To make buying easier, we've prepared a table with offers from these brokers, including quick purchase of Exact Sciences stocks through mobile apps with client support. In this table, you can compare brokers offering real Exact Sciences stocks. Brokers providing the option to buy real stocks (not CFDs) are identified by "Real Stocks" in the comparison table column.
| Broker | Platforms | Regulation | Min. Deposit | Deposits / Withdrawals | CopyTrader | Real Stocks | Website Link |
|---|---|---|---|---|---|---|---|
 |
Proprietary platform, social network + CopyTrader™ | 100 USD | Bank transfer, credit cards, Skrill, PayPal, Neteller |
 Go to eToro
|
|||
 |
xStation, mobile version | 10 USD | Credit cards, Skrill, bank transfer |
 Go to XTB
|
|
|
| xStation, mobile version | Proprietary platform, social network + CopyTrader™ |
|
Go to XTB
|
Go to eToro
|
More Information about Exact Sciences (EXAS)
Exact Sciences consistently proves itself as a leader in its industry. Total revenues for the last 12 months exceed 2,499,766,016.00 USD, demonstrating its strong market position and ability to generate high revenues. Negative EBITDA of -102,227,000.00 USD may indicate challenges but also opportunities for Exact Sciences to invest in future growth. Debt-to-equity ratio of 0.82 suggests that Exact Sciences has a healthy financial structure and effectively manages its debts. This is key to stable growth. Gross margin of 73.83% shows that Exact Sciences efficiently manages costs and maintains a high share of revenues. This is a sign of a strong market position. Lower profit margin of -8.17% suggests opportunities for Exact Sciences to increase efficiency and reduce costs.
| Indicator | Value |
|---|---|
| Revenue, Debt, and Cash Flow | |
| Company Revenue: | 2,499,766,016.00 USD |
| EBITDA: | -102,227,000.00 USD - Negative EBITDA may signal financial challenges or growth investments. |
| Earnings Per Share: | -1.13 USD |
| Book Value Per Share: | 17.34 USD |
| Total Cash: | 777,644,032.00 USD |
| Total Cash per Share: | 4.28 USD |
| Total Debt: | 2,566,625,024.00 USD |
| Debt to Equity Ratio: | 0.82 |
| Quick Ratio: | 1.91 |
| Current Ratio: | 2.32 |
| Free Cash Flow: | 91,769,752.00 USD |
| Operating Cash Flow: | 156,119,008.00 USD |
| Company Margins | |
| Gross Margins: | 73.83 % |
| EBITDA Margins: | -4.09 % |
| Operating Margins: | -11.94 % |
| Profit Margins: | -8.17 % |
| Performance | |
| Return on Assets: | -3.0 % |
| Return on Equity: | -6.6 % |
| Earnings Growth (1 year): | / |
| Revenue Growth (1 year): | 17.0 % |
| Year-over-Year Quarterly Earnings Growth: | / |
| Valuation | |
| Market Capitalization: | 11,130,278,912.00 USD |
| Enterprise Value: | 12,778,865,664.00 USD |
| EV/Revenue: | 5.112 |
| EV/EBITDA: | -125.005 |
| Number of Shares and Short Shares | |
| Float Shares: | 179,648,491 shares |
| Shares Outstanding: | 183,850,000 shares |
| Held Percent Insiders: | 0.01 % |
| Held Percent Institutions: | 84.49 % |
| Shares Short: | 9,892,023 |
| Shares Short Prior Month: | 6,518,992 |
| Date Short Interest: | 2024-04-15 |
| Shares Percent Shares Out: | 5.38 % |
| Short Ratio: | 3.12 |
| Beta: | 1.23 |
| Short Percent of Float: | 5.43 % |
| Předpokládaný počet akcií: | 183,850,000 |
Frequently Asked Questions (FAQ)
According to our data, Exact Sciences does not currently pay dividends, even in 2024.
Exact Sciences shares are traded on the stock exchange NasdaqCM under the ticker symbol: EXAS. You can buy or trade them with a variety of stock brokers offering real stock trading services.
According to our data, there is a buy recommendation issued for Exact Sciences shares by a total of 20 analysts. The average target price prediction is 89.6 USD per share.
The total number of Exact Sciences shares on the exchange is 183,850,000.00, which, at the current market capitalization, values the company at 11,130,278,912.00 USD.
